Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Nevertheless, these studys findings are significant, as they demonstrate that once-weekly semaglutide for patients with heart failure with preserved ejection fraction can lead to significant improvements in exercise and weight loss as well as reductions in heart failure-related symptoms
Point-of-care gastric ultrasound has become a valuable tool that identifies patients with higher aspiration risk [35]
GLP-1 medications appear to provide kidney protection beyond what glucose control alone achieves
Prescription of guideline-directed medical therapies in patients with diabetes and chronic kidney disease from the CURE-CKD Registry, 2019-2020
"ATTAINMAINTAIN showed that orforglipron, a once-daily oral GLP-1, helped people maintain the weight they worked hard to lose." This data provides the first robust, Phase 3 evidence that an oral "step-down" or "switch" strategy is not just feasible but effective, offering a new pathway for the long-term management of obesity
Together, these episodes explore how GLP-1 medications work, who theyre designed for, their potential benefits and risks, what were seeing both in practice and in the broader population, what the science says, and what active people need to know
